ArticleBasic research in cardiology2026
Cardiomyocyte-specific depletion of integrin α3 preserves cardiac function after myocardial infarction.
Article in Basic research in cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Integrins, a family of transmembrane receptors that mediate cell-extracellular (ECM) interactions, play a pivotal role in the heart to maintain cardiac function and tissue integrity. As they sense extracellular signals, their expression changes in a microenvironment-dependent manner. Especially following myocardial infarction (MI), several alpha integrins are upregulated. Integrin α3 (ITGA3) expression has been found upregulated after MI, yet little is known about the function of ITGA3 in cardiac tissue. To evaluate the role of ITGA3 in vivo. we generated a mouse line with cardiomyocytes-specific ITGA3 depletion (ITGA3 KO). ITGA3 KO mice were characterized under baseline conditions and after permanent LAD ligation by echocardiography. Cardiac tissue was processed for histological staining (WGA/Sirius-Red) and molecular analysis by qPCR and WB. Identified changes were proven in vitro using coculturing model of neonatal rat cardiac fibroblasts (NRCFs) with siRNA treated neonatal rat cardiomyocytes (NRCMs) lacking ITGA3. ITGA3 KO mice did not show any disadvantageous alterations in cardiac function and structure under baseline conditions. After experimental MI, cardiac function was preserved and hypertrophic response diminished in ITGA3 KO. Development of fibrosis and the induction of pathological gene program was attenuated. Mechanistically, we identified an upregulation in Hippo signalling and activation of autophagic processes (ATG5 and p62 levels as well as enhanced LC3 II/I ratios) in ITGA3 KO mice after MI, which was confirmed by in-vitro experiments of NRCMs. Our findings show that in vivo depletion of ITGA3 in adult cardiomyocytes preserves cardiac function and reduces pathological remodelling after MI. Thus, interference with ITGA3 might be a novel translational approach to improve cardiac remodelling after ischemic injury.
Indexed as
Identifiers
42426313What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.